Other Assets, Current of PROVECTUS BIOPHARMACEUTICALS, INC. from 31 Dec 2014 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current assets classified as other.
Summary
PROVECTUS BIOPHARMACEUTICALS, INC. quarterly Other Assets, Current in USD history and change rate from 31 Dec 2014 to 30 Sep 2025.
  • PROVECTUS BIOPHARMACEUTICALS, INC. Other Assets, Current for the quarter ending 30 Sep 2025 was $90,844.
Source SEC data
View on sec.gov
Other Assets, Current, Quarterly (USD)
Other Assets, Current, YoY Quarterly Change (%)

PROVECTUS BIOPHARMACEUTICALS, INC. Quarterly Other Assets, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $90,844 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 $2,811 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q4 2024 $237,979 31 Dec 2024 10-Q 13 Nov 2025 2025 Q3
Q2 2017 $244,997 -$71,588 -23% 30 Jun 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 $250,515 -$86,376 -26% 31 Mar 2017 10-Q 10 May 2017 2017 Q1
Q4 2016 $360,562 +$319,370 +775% 31 Dec 2016 10-Q 09 Aug 2017 2017 Q2
Q3 2016 $187,222 -$878,734 -82% 30 Sep 2016 10-Q 09 Nov 2016 2016 Q3
Q2 2016 $316,585 -$869,216 -73% 30 Jun 2016 10-Q 09 Aug 2016 2016 Q2
Q1 2016 $336,891 -$886,777 -72% 31 Mar 2016 10-Q 10 May 2016 2016 Q1
Q4 2015 $41,192 -$936,808 -96% 31 Dec 2015 10-K 31 Mar 2017 2016 FY
Q3 2015 $1,065,956 30 Sep 2015 10-Q 05 Nov 2015 2015 Q3
Q2 2015 $1,185,801 30 Jun 2015 10-Q 06 Aug 2015 2015 Q2
Q1 2015 $1,223,668 31 Mar 2015 10-Q 07 May 2015 2015 Q1
Q4 2014 $978,000 31 Dec 2014 10-K 30 Mar 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.